Market closed

Vor Biopharma/$VOR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Vor Biopharma

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Ticker

$VOR
Trading on

Industry

Biotechnology

Employees

168

Vor Biopharma Metrics

BasicAdvanced
$60M
Market cap
-
P/E ratio
-$1.65
EPS
-0.41
Beta
-
Dividend rate
$60M
-0.41
$3.14
$0.63
553K
4.691
4.378
39.327
45.033
-43.51%
-90.79%
0.82
0.82
-0.592
-12.02%
-17.03%

What the Analysts think about Vor Biopharma

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Vor Biopharma stock.

Vor Biopharma Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Vor Biopharma Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VOR

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vor Biopharma stock?

Vor Biopharma (VOR) has a market cap of $60M as of December 24, 2024.

What is the P/E ratio for Vor Biopharma stock?

The price to earnings (P/E) ratio for Vor Biopharma (VOR) stock is 0 as of December 24, 2024.

Does Vor Biopharma stock pay dividends?

No, Vor Biopharma (VOR) stock does not pay dividends to its shareholders as of December 24, 2024.

When is the next Vor Biopharma dividend payment date?

Vor Biopharma (VOR) stock does not pay dividends to its shareholders.

What is the beta indicator for Vor Biopharma?

Vor Biopharma (VOR) has a beta rating of -0.41. This means that it has an inverse relation to market volatility.